Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
|
Device | FoundationOne®Liquid CDx |
Generic Name | Next generation sequencing oncology panel, somatic or germline variant detection system |
Applicant | Foundation Medicine, Inc. 150 Second Street Cambridge, MA 02141 |
PMA Number | P200006 |
Supplement Number | S002 |
Date Received | 08/22/2022 |
Decision Date | 09/21/2022 |
APCB Date
|
05/26/2023 |
Product Code |
PQP |
Advisory Committee |
Pathology |
Supplement Type | Special (Immediate Track) |
Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement Approval for the formatting and updates to the Specimen Instructions document, the technical labeling, and the mock patient reports for FoundationOne® Liquid CDx. |
|
|